SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000819050-21-000049
Filing Date
2021-03-24
Accepted
2021-03-24 16:14:22
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A a20210324defa-14a.htm DEFA14A 25225
2 recommendation1a.jpg GRAPHIC 109773
3 reminder1a.jpg GRAPHIC 79037
  Complete submission text file 0000819050-21-000049.txt   286404
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Brickell Biotech, Inc. (Filer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-21088 | Film No.: 21768357
SIC: 2836 Biological Products, (No Diagnostic Substances)